Literature DB >> 4150762

Proceedings: Preliminary observations on the human pharmacology of I.C.I. 66082 in normal volunteers.

B R Graham, D W Littlejohns, B N Prichard, B Scales, P Southorn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4150762      PMCID: PMC1776414     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  2 in total

1.  The blocking effects of propranolol, practolol and ICI-66082 on the peripheral vascular responses to isoprenaline.

Authors:  R Hainsworth; F Karim; J B Stoker; J D Harry
Journal:  Br J Pharmacol       Date:  1973-06       Impact factor: 8.739

2.  A new type of cardioselective adrenoceptive blocking drug.

Authors:  A M Barrett; J Carter; J D Fitzgerald; R Hull; D Le Count
Journal:  Br J Pharmacol       Date:  1973-06       Impact factor: 8.739

  2 in total
  11 in total

Review 1.  Hypertension: which beta-blocker?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

2.  A simple spectrophotofluorometric method for the measurement of I.C.I. 66082 in plasma and urine.

Authors:  C M Kaye
Journal:  Br J Clin Pharmacol       Date:  1974-02       Impact factor: 4.335

3.  The influence of urine pH on the renal excretion of ICI 66082 in man.

Authors:  C M Kaye
Journal:  Br J Clin Pharmacol       Date:  1974-12       Impact factor: 4.335

4.  An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man.

Authors:  G E Marlin; C R Kumana; C M Kaye; D M Smith; P Turner
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

5.  The role of beta-adrenoceptors in the responses of the hepatic arterial vascular bed of the dog to phenylephrine, isoprenaline, noradrenaline and adrenaline.

Authors:  P D Richardson; P G Withrington
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

Review 6.  Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-06       Impact factor: 9.546

Review 7.  Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.

Authors:  G Johnsson; C G Regàrdh
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

8.  Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man.

Authors:  J F De Plaen; A Amery; T Reybrouck
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

9.  The distribution of propranolol, pindolol and atenolol between human erythrocytes and plasma.

Authors:  E A Taylor; P Turner
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

Review 10.  Clinical pharmacokinetics of atenolol--a review.

Authors:  W Kirch; K G Görg
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.